Clinical Trial Update: Anti TNF α Improves Endothelial Dysfunction in IBD Patients

View source ↗

Summary

A clinical trial update indicates that anti-TNF alpha therapy improves endothelial dysfunction in patients with Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Anti-TNF-alpha therapy

Snippet

Sponsor: Carmel Medical Center | Conditions: Crohn's Disease | Status: UNKNOWN